Protocol for an economic analysis of the randomised controlled trial of Improving the Well-being of people with Opioid Treated CHronic pain: I-WOTCH Study.
Protocol for an economic analysis of the randomised controlled trial of Improving the Well-being of people with Opioid Treated CHronic pain: I-WOTCH Study.
复制标题
DOI:
10.1136/bmjopen-2020-037243
复制
发表时间:
2020-11-20
期刊:
影响因子:
2.9
通讯作者:
I-WOTCH team
中科院分区:
文献类型:
--
作者:
Manchira Krishnan S;Gc VS;Sandhu HK;Underwood M;Eldabe S;Manca A;Iglesias Urrutia CP;I-WOTCH team
Over the last two decades, the use of opioids for the treatment of chronic pain in England has steadily increased despite lack of evidence of both long-term effectiveness in pain relief and significant, well-documented physical and mental adverse events. Guidelines recommend tapering when harms outweigh benefits, but the addictive nature of opioids hinders simple dose-reduction strategies. Improving the Well-being of people with Opioid Treated CHronic pain (I-WOTCH) trial tests a multicomponent self-management intervention aimed to help patients with chronic non-malignant pain taper opioid doses. This paper outlines the methods to be used for the economic analysis of the I-WOTCH intervention compared with the best usual care. Economic evaluation alongside the I-WOTCH study, prospectively designed to identify, measure and value key healthcare resource use and outcomes arising from the treatment strategies being compared. A within-trial cost-consequences analysis and a model-based long-term cost-effectiveness analysis will be conducted from the National Health Service and Personal Social Service perspective in England. The former will quantify key parameters to populate a Markov model designed to estimate the long-term cost and quality-adjusted life years of the I-WOTCH intervention against best usual care. Regression equations will be used to estimate parameters such as transition probabilities, utilities, and costs associated with the model’s states and events. Probabilistic sensitivity analysis will be used to assess the impact of parameter uncertainty onto the predicted costs and health outcomes, and the resulting value for money assessment of the I-WOTCH intervention. Full ethics approval was granted by Yorkshire & The Humber—South Yorkshire Research Ethics Committee on 13 September 2016 (16/YH/0325). Current protocol: V.1.7, date 31 July 2019. Findings will be disseminated in peer-reviewed journals, scientific conferences, newsletters and websites. International Standard Randomised Controlled Trial Number (49 470 934); Pre-result.
登录
查看更多内容
影响因子:
64.3
作者:
Curtis, Helen J.;Croker, Richard;Goldacre, Ben
通讯作者:
Goldacre, Ben
影响因子:
2.4
作者:
Ikenberg, Robert;Hertel, Nadine;Liedgens, Hiltrud
通讯作者:
Liedgens, Hiltrud
DOI:
10.1001/jama.2016.1464
发表时间:
2016-04-19
期刊:
JAMA
影响因子:
--
作者:
Dowell D;Haegerich TM;Chou R
通讯作者:
Chou R
影响因子:
3.5
作者:
Herdman, M.;Gudex, C.;Lloyd, A.;Janssen, M. F.;Kind, P.;Parkin, D.;Bonsel, G.;Badia, X.
通讯作者:
Badia, X.
影响因子:
4.4
作者:
Faria, Rita;Gomes, Manuel;Epstein, David;White, Ian R.
通讯作者:
White, Ian R.